# SPECTACL: SPECTroscopic Assessment of Coronary Lipid

> **NCT00330928** · PHASE2,PHASE3 · COMPLETED · sponsor: **Infraredx** · enrollment: 106 (actual)

## Conditions studied

- Angina Pectoris
- Angina, Unstable
- Myocardial Infarction

## Interventions

- **DEVICE:** Near Infrared Spectroscopy (NIRS) Imaging
- **DEVICE:** intravascular ultrasound (IVUS)

## Key facts

- **NCT ID:** NCT00330928
- **Lead sponsor:** Infraredx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-10
- **Final completion:** 2008-10
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00330928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00330928, "SPECTACL: SPECTroscopic Assessment of Coronary Lipid". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00330928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*